- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07819617
Submental Island Flap vs Radial Forearm Free Flap in Tongue Reconstruction (SIPF-RFFF)
Evaluation of Quality of Life Post Tongue Cancer Resection and Reconstruction Using Submental Island Pedicled Flap Versus Radial Forearm Free Flap
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Surgical reconstruction following tongue cancer resection is essential for restoring oral function, speech, swallowing, and facial aesthetics. The Radial Forearm Free Flap (RFFF) is widely considered a gold standard for soft tissue oral reconstruction; however, it requires microvascular expertise and carries donor-site morbidity. The Submental Island Pedicled Flap (SIPF) serves as an alternative, offering a reliable regional pedicled flap with local color match and simplified surgical execution without requiring microvascular anastomoses.
This retrospective observational cohort study aims to compare patients who received SIPF versus RFFF for tongue reconstruction. The primary objective is to evaluate health-related quality of life outcomes using the validated University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), alongside evaluating postoperative surgical outcomes and donor site morbidity.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Assuit
-
Asyut, Assuit, Egypte
- Faculty of Dental Medicine, Al-Azhar University (Assiut Branch)
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Adult patients (aged 18 years or older) diagnosed with squamous cell carcinoma of the tongue requiring partial or total glossectomy.
- Indication for immediate soft tissue reconstruction using either Submental Island Pedicled Flap (SIPF) or Radial Forearm Free Flap (RFFF).
- Patients eligible and cleared for major surgical resection and flap reconstruction under general anesthesia.
- Patient's informed consent to participate in the study and complete follow-up evaluations.
Exclusion Criteria:
- History of previous radiation therapy or surgical intervention in the head and neck region.
- Clinical or radiological evidence of nodal metastasis in level I submental lymph nodes (for SIPF candidates).
- Severe systemic comorbidities precluding major surgery or prolonged general anesthesia (ASA class IV or higher).
- Distance or inability to commit to the 12-month postoperative follow-up schedule and quality of life assessments.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
SIPF Group
Patients who underwent tongue reconstruction using Submental Island Pedicled Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a pedicled submental island flap.
|
|
RFFF group
Patients who underwent tongue reconstruction using Radial Forearm Free Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a microvascular radial forearm free flap.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
12-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
Délai: 12 months post operatively
|
Unweighted composite score calculated as the mean of all 12 domains of the University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), evaluated at 12 months postoperatively and adjusted for baseline composite score using analysis of covariance (ANCOVA).
Scores range from 0 to 100, where higher scores indicate better quality of life.
|
12 months post operatively
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
6-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
Délai: 6 months post operatively
|
Unweighted composite score of the 12 UW-QOL v4 domains evaluated at 6 months postoperatively and adjusted for baseline composite score using ANCOVA.
Scores range from 0 to 100.
|
6 months post operatively
|
|
Operative time
Délai: Day of surgery (intraoperative)
|
Total duration of surgery measured in hours from initial skin incision to final closure.
|
Day of surgery (intraoperative)
|
|
Length of hospital stay
Délai: From date of surgery to hospital discharge. Up to 30 days
|
Total duration of inpatient hospital admission measured in days from surgery until discharge.
|
From date of surgery to hospital discharge. Up to 30 days
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Mohamed Serag Attia, MSc, Al-Azhar University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AUAREC20240007-3
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .